| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.2 |